text
"[""\nX. 대주주 등과의 거래내용\n가. 대주주 등에 대한 신용공여 등해당사항 없습니다.나. 대주주와의 자산양수도 및 영업거래 등보고서 작성기준일 현재 회사의 대주주 및 특수관계자 등에 대한 재화의 판매 또는 용역의 제공과 구입내역은 다음과 같습니다. 자세한 내역은 'III. 재무에 관한 사항 - 3. 연결재무제표 주석 - 23. 특수관계자 거래'를 참고하시기 바랍니다.[당반기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스제공\n임대수익\n기타\n재고자산매입 등\n유무형자산매입\n용역/서비스비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n134,655\n90,385\n368,898\n3,198\n-\n-\n19,583,577\n11,374,822\n-\n관계기업\n(주)아피셀테라퓨틱스\n983\n85,275\n-\n-\n-\n-\n-\n-\n-\nImmplacate, INC.\n-\n-\n-\n10,095\n-\n-\n-\n-\n-\nNurron Pharmaceuticals, INC.\n-\n-\n-\n954,669\n-\n-\n-\n-\n-\nAEON Biopharma, Inc.\n-\n-\n-\n776,267\n-\n-\n-\n-\n-\n기타특수관계자\n대웅바이오(주)\n10,514,046\n1,408,054\n-\n7,585\n35,102,008\n-\n19,943,436\n17,403\n-\n(주)HR그룹\n-\n-\n-\n-\n-\n-\n600\n-\n1,598\n(주)아이디에스앤트러스트\n2,174\n16,182\n27,090\n-\n-\n149,300\n234,440\n-\n13,669\n(주)대웅경영개발원\n1,350\n-\n30,066\n328,019\n-\n-\n12,599\n-\n295,590\n(주)대웅생명과학\n-\n-\n-\n-\n-\n-\n-\n-\n175,508\n(주)대웅개발\n7,244\n14,200\n447,222\n-\n116,238\n-\n1,468,892\n7,757\n542,267\n(주)에스티에이치이솔루션\n-\n2,240\n-\n-\n-\n-\n5,403\n-\n27\n(주)대웅펫\n201,798\n-\n20,328\n29,881\n-\n-\n-\n608,271\n19,231\n(주)대웅테라퓨틱스\n129,521\n-\n-\n-\n2,448\n150,000\n5,000\n2,620,000\n-\n(주)대웅인베스트먼트\n-\n-\n4,452\n-\n-\n-\n-\n-\n-\n(주)픽스젠테라퓨틱스\n-\n-\n597\n-\n-\n-\n-\n-\n-\n(주)알피스페이스\n-\n-\n-\n-\n216,281\n-\n-\n50\n600,864\n(주)알피바이오\n-\n-\n-\n-\n2,463,413\n-\n240\n-\n-\n(주)이지메디컴\n1,273,674\n16,800\n-\n-\n-\n156,345\n677,010\n23,467\n3,260,141\n(주)시지바이오\n971,135\n1,649,731\n75,600\n68,583\n6,279,741\n-\n351,383\n-\n430,819\n(주)바이오에이지\n233\n870\n-\n-\n11,700\n-\n2,542\n4,400\n345,760\n(주)디엔홀딩스\n-\n-\n198\n18,419\n-\n-\n-\n-\n-\n(주)디엔코스메틱스\n949,854\n172,192\n16,932\n943\n701,404\n-\n1,793\n7,805\n1,231,752\n(주)디엔컴퍼니\n10,745,585\n6,264\n240\n12,780\n-\n-\n139,054\n1,400\n-\n(주)엠서클\n50,586\n26,291\n-\n-\n153,740\n-\n3,722,391\n380\n2,656,636\n기타\n464,175\n10,034\n45,619\n-\n79,724\n165,274\n3,242,287\n2,017\n1,540,343\n합 \xa0계\n25,447,013\n3,498,518\n1,037,242\n2,210,439\n45,126,697\n620,919\n49,390,647\n14,667,772\n11,114,205\n[전반기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스제공\n임대수익\n기타\n재고자산매입 등\n용역/서비스비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n196,743\n98,650\n343,972\n-\n-\n18,598,195\n9,405,383\n2,047\n관계기업\n(주)엠디웰아이앤씨\n6,996\n930\n9,763\n-\n1,187\n50,257\n91\n62,549\n(주)바이오시네틱스\n-\n-\n-\n-\n-\n370\n1,480\n-\n(주)다나아데이터\n-\n-\n4,800\n-\n-\n-\n-\n-\nImmplacate, INC.\n-\n-\n-\n9,632\n-\n-\n-\n-\n기타특수관계자\n대웅바이오(주)\n9,310,888\n96,800\n-\n-\n28,626,204\n14,364,804\n3,010\n-\n(주)아이디에스앤트러스트\n11,026\n19,140\n49,632\n5,885\n53,708\n258,288\n260,898\n-\n(주)대웅경영개발원\n300\n-\n83,207\n-\n3,373\n40,844\n141,416\n189,327\n(주)대웅생명과학\n-\n-\n-\n-\n273\n-\n-\n235,680\n(주)대웅이엔지\n2,130\n10,005\n1,523\n1,661\n5,192,392\n450,256\n121,276\n216,754\n(주)산웅개발\n132\n-\n-\n-\n22,487\n143,524\n-\n54,025\n(주)대웅개발\n-\n671\n379,688\n-\n56,540\n318,638\n-\n587,030\n(주)팜팩\n4,361\n-\n170\n-\n1,226,334\n-\n-\n-\n(주)에스티에이치이솔루션\n-\n2,923\n-\n-\n-\n15,501\n-\n3,318\n(주)대웅펫\n27,082\n1,725\n21,227\n-\n2,454\n126\n303,709\n30,728\n(주)대웅테라퓨틱스\n3,750\n-\n-\n-\n-\n-\n1,200,000\n-\n(주)디더블유메디팜\n-\n-\n-\n830\n268,314\n-\n79,900\n8,949\n(주)대웅인베스트먼트\n-\n-\n2,491\n10,715\n-\n-\n-\n-\n(주)알피스페이스\n-\n4,093\n-\n-\n158,299\n1,403\n50\n827,045\n(주)알피바이오\n-\n-\n-\n-\n2,864,568\n-\n-\n-\n(주)이지메디컴\n1,128,940\n6,590\n-\n-\n-\n464,841\n5,844\n2,641,486\n(주)시지바이오\n1,136,009\n58,812\n75,600\n-\n4,140,345\n137,484\n-\n25,924\n(주)바이오에이지\n307\n870\n-\n-\n9,000\n-\n9,600\n288,385\n(주)디엔홀딩스\n1,056\n2,958\n15,512\n7,300\n-\n-\n-\n-\n(주)디엔코스메틱스\n647,375\n7,382\n15,512\n4,831\n900,471\n-\n3,003\n988,714\n(주)디엔컴퍼니\n9,677,751\n7,134\n38,595\n-\n-\n370,809\n-\n-\n(주)엠서클\n28,204\n33,144\n58,505\n-\n114,353\n6,896,729\n5,464\n3,628,004\n기타\n995,425\n56,208\n45,612\n-\n535\n75,428\n3,960\n119,435\n합 \xa0계\n23,178,475\n408,035\n1,145,809\n40,854\n43,640,837\n42,187,497\n11,545,084\n9,909,400\n""]"
